Conn. Jury Hands Boehringer 3rd Straight Pradaxa Trial Win

By Daniel Siegal (October 9, 2018, 1:22 PM EDT) -- Boehringer Ingelheim Pharmaceuticals has won its third straight bellwether trial over the alleged bleeding risk of its blood thinner Pradaxa, after a Connecticut state jury rejected a man's claims that the drug caused a life-threatening bout of internal bleeding....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!